home / stock / plx / plx news


PLX News and Press, Protalix BioTherapeutics Inc. From 11/06/23

Stock Information

Company Name: Protalix BioTherapeutics Inc.
Stock Symbol: PLX
Market: NYSE
Website: protalix.com

Menu

PLX PLX Quote PLX Short PLX News PLX Articles PLX Message Board
Get PLX Alerts

News, Short Squeeze, Breakout and More Instantly...

PLX - Protalix Biotherapeutics, Inc. (PLX) Q3 2023 Earnings Call Transcript

2023-11-06 11:57:05 ET Protalix Biotherapeutics, Inc. (PLX) Q3 2023 Earnings Conference Call November 6, 2023 8:30 AM ET Company Participants Chuck Padala - Managing Director, Investor Relations Dror Bashan - President and Chief Executive Officer Eyal Rubin - Sen...

PLX - American Well, Protalix BioTherapeutics among healthcare movers

2023-11-06 10:01:49 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in F...

PLX - ARVL, PSTV and TALK among pre-market losers

2023-11-06 08:17:52 ET Losers: MoonLake Immunotherapeutics ( MLTX ) -30% . Tecnoglass ( TGLS ) -15% after Q3 earning release . Kodiak Sciences ( KOD ) -11% says Phase 3 trial for lead asset met key goals. Arrival ( ARVL ) -9% . A...

PLX - Protalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $10.35M beats by $2.71M

2023-11-06 06:53:00 ET More on Protalix BioTherapeutics Protalix BioTherapeutics Stock Is A Hold Pending Successful Commercialization Of Elfabrio Nano-X, InMode, Teva among notable Israel-based healthcare decliners Seeking Alpha’s Quant Rating on Protalix BioT...

PLX - Upcoming Earning Release Paired With Price Target Raise Sends Stock Soaring

2023-10-31 15:49:03 ET A New Jersey-based %Healthcare company turned heads on Tuesday following HC Wainwright & Co. maintaining a buy rating while raising its price target from $7 to $10/share. This report came one day following the company’s announcement that it will be rele...

PLX - Amicus Therapeutics: The Right Play Now

2023-10-31 12:24:58 ET Summary Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rare diseases. The company recently received FDA approval for its combination therapy Pombiliti + Opfolda for Pompe disease. Amicus Therapeutics i...

PLX - Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023

Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023 PR Newswire Company to host conference call and webcast at 8:30 a.m. EST CARMIEL, Israel , Oct. 30, 2023 /PRNewswire/ -- Protalix BioTherapeutic...

PLX - Palatin Technologies, Protalix BioTherapeutics, Arcutis among healthcare movers

2023-10-20 10:06:59 ET More on Health Care: Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employment To Infinity Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the...

PLX - Nano-X, InMode, Teva among notable Israel-based healthcare decliners

2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...

PLX - BTBT, SFT and BLRX among pre-market losers

2023-10-09 08:23:30 ET More on InMode, Mirati Therapeutics, etc. InMode: Bullish Support Failed To Materialize InMode: Strong Net Cash Position Sets The Stage For Opportunistic Buybacks InMode: Be Greedy When Others Are Fearful Bristol-Myers Squibb to acquire...

Previous 10 Next 10